BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28661490)

  • 1. Mutations in C-natriuretic peptide (NPPC): a novel cause of autosomal dominant short stature.
    Hisado-Oliva A; Ruzafa-Martin A; Sentchordi L; Funari MFA; Bezanilla-López C; Alonso-Bernáldez M; Barraza-García J; Rodriguez-Zabala M; Lerario AM; Benito-Sanz S; Aza-Carmona M; Campos-Barros A; Jorge AAL; Heath KE
    Genet Med; 2018 Jan; 20(1):91-97. PubMed ID: 28661490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature in patients initially classified as idiopathic short stature.
    Vasques GA; Amano N; Docko AJ; Funari MF; Quedas EP; Nishi MY; Arnhold IJ; Hasegawa T; Jorge AA
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1636-44. PubMed ID: 24001744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature.
    Wang SR; Jacobsen CM; Carmichael H; Edmund AB; Robinson JW; Olney RC; Miller TC; Moon JE; Mericq V; Potter LR; Warman ML; Hirschhorn JN; Dauber A
    Hum Mutat; 2015 Apr; 36(4):474-81. PubMed ID: 25703509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of NPR2 mutation in idiopathic short stature: Identification of two novel mutations.
    Hwang IT; Mizuno Y; Amano N; Lee HJ; Shim YS; Nam HK; Rhie YJ; Yang S; Lee KH; Hasegawa T; Kang MJ
    Mol Genet Genomic Med; 2020 Mar; 8(3):e1146. PubMed ID: 31960617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypomorphic mutation in mouse Nppc gene causes retarded bone growth due to impaired endochondral ossification.
    Tsuji T; Kondo E; Yasoda A; Inamoto M; Kiyosu C; Nakao K; Kunieda T
    Biochem Biophys Res Commun; 2008 Nov; 376(1):186-90. PubMed ID: 18775416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the natriuretic peptide system in normal growth and growth disorders.
    Vasques GA; Arnhold IJ; Jorge AA
    Horm Res Paediatr; 2014; 82(4):222-9. PubMed ID: 25196103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and functional characterization of two novel NPR2 mutations in Japanese patients with short stature.
    Amano N; Mukai T; Ito Y; Narumi S; Tanaka T; Yokoya S; Ogata T; Hasegawa T
    J Clin Endocrinol Metab; 2014 Apr; 99(4):E713-8. PubMed ID: 24471569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced ability of C-type natriuretic peptide (CNP) to activate natriuretic peptide receptor B (NPR-B) causes dwarfism in lbab -/- mice.
    Yoder AR; Kruse AC; Earhart CA; Ohlendorf DH; Potter LR
    Peptides; 2008 Sep; 29(9):1575-81. PubMed ID: 18554750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics of Short-Stature Patients With an NPR2 Mutation and the Therapeutic Response to rhGH.
    Ke X; Liang H; Miao H; Yang H; Wang L; Gong F; Pan H; Zhu H
    J Clin Endocrinol Metab; 2021 Jan; 106(2):431-441. PubMed ID: 33205215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic Peptide Expression and Function in GH3 Somatolactotropes and Feline Somatotrope Pituitary Tumours.
    Mirczuk SM; Scudder CJ; Read JE; Crossley VJ; Regan JT; Richardson KM; Simbi B; McArdle CA; Church DB; Fenn J; Kenny PJ; Volk HA; Wheeler-Jones CP; Korbonits M; Niessen SJ; McGonnell IM; Fowkes RC
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygous NPR2 Mutations Cause Disproportionate Short Stature, Similar to Léri-Weill Dyschondrosteosis.
    Hisado-Oliva A; Garre-Vázquez AI; Santaolalla-Caballero F; Belinchón A; Barreda-Bonis AC; Vasques GA; Ramirez J; Luzuriaga C; Carlone G; González-Casado I; Benito-Sanz S; Jorge AA; Campos-Barros A; Heath KE
    J Clin Endocrinol Metab; 2015 Aug; 100(8):E1133-42. PubMed ID: 26075495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short Stature is Progressive in Patients with Heterozygous NPR2 Mutations.
    Hanley PC; Kanwar HS; Martineau C; Levine MA
    J Clin Endocrinol Metab; 2020 Oct; 105(10):3190-202. PubMed ID: 32720985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and in silico analyses validates pathogenicity of homozygous mutations in the NPR2 gene underlying variable phenotypes of Acromesomelic dysplasia, type Maroteaux.
    Irfanullah ; Zeb A; Shinwari N; Shah K; Gilani SZT; Khan S; Lee KW; Raza SI; Hussain S; Liaqat K; Ahmad W
    Int J Biochem Cell Biol; 2018 Sep; 102():76-86. PubMed ID: 30016695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single nucleotide mutation in Nppc is associated with a long bone abnormality in lbab mice.
    Jiao Y; Yan J; Jiao F; Yang H; Donahue LR; Li X; Roe BA; Stuart J; Gu W
    BMC Genet; 2007 Apr; 8():16. PubMed ID: 17439653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biallelic cGMP-dependent type II protein kinase gene (
    Díaz-González F; Wadhwa S; Rodriguez-Zabala M; Kumar S; Aza-Carmona M; Sentchordi-Montané L; Alonso M; Ahmad I; Zahra S; Kumar D; Kushwah N; Shamim U; Sait H; Kapoor S; Roldán B; Nishimura G; Offiah AC; Faruq M; Heath KE
    J Med Genet; 2022 Jan; 59(1):28-38. PubMed ID: 33106379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature.
    Olney RC; Bükülmez H; Bartels CF; Prickett TC; Espiner EA; Potter LR; Warman ML
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1229-32. PubMed ID: 16384845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and Genetic Disruption of C-Type Natriuretic Peptide (
    Lessey AJ; Mirczuk SM; Chand AN; Kurrasch DM; Korbonits M; Niessen SJM; McArdle CA; McGonnell IM; Fowkes RC
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn/cn mouse.
    Tsuji T; Kunieda T
    J Biol Chem; 2005 Apr; 280(14):14288-92. PubMed ID: 15722353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying therapeutic drug targets using bidirectional effect genes.
    Estrada K; Froelich S; Wuster A; Bauer CR; Sterling T; Clark WT; Ru Y; Trinidad M; Nguyen HP; Luu AR; Wendt DJ; Yogalingam G; Yu GK; LeBowitz JH; Cardon LR
    Nat Commun; 2021 Apr; 12(1):2224. PubMed ID: 33850126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nppc/Npr2/cGMP signaling cascade maintains oocyte developmental capacity.
    Celik O; Celik N; Ugur K; Hatirnaz S; Celik S; Muderris II; Yavuzkir S; Sahin İ; Yardim M; Aydin S
    Cell Mol Biol (Noisy-le-grand); 2019 Apr; 65(4):83-89. PubMed ID: 31078160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.